Complaints Outcomes

Search

Search Results

Search Again
Sands, Ian Colin (Jun 22, 2015)
(Dec 15, 2015 - REGIStration Reinstated)

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached a Consent Agreement with Mr. Ian Colin Sands, effective June 22, 2015, in which he agreed to a temporary suspension of his pharmacist licence. This was the result of investigations conducted on a pharmacy under the management of Mr. Sands where several practice violations and illegal transport of controlled substances were allegedly found.  Mr. Sands agreed to the following terms, among others:

  1. Suspension of registration as a pharmacist until December 15, 2015, effective immediately. 
  2. Upon reinstatement from suspension, prohibition from acting as a pharmacy manager until June 15, 2016. 
  3. Notification about this suspension will be published on the College website, pursuant to s. 39.3 of the Health Professions Act.

In the same Consent Agreement, Mr. Sands also agreed to not repeat the alleged conduct, to thoroughly review the legislation which he had breached and to discontinue a court action against the College which he had commenced.

Choi, Hong Yee Alan (Jun 1, 2015)

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached a Consent Agreement with Mr. Hong Yee Alan Choi, effective June 1, 2015.  This was the result of an investigation of Mr. Choi, pharmacy manager, in which a coroner’s report indicated a patient died from complications of multi-drug ingestion including methadone on a Sunday. This patient had recently restarted a maintenance methadone treatment program.  Mr. Choi dispensed methadone to the patient on a Saturday and provided the patient with an unauthorized carry for the next day - Sunday. The patient’s methadone prescription was for daily witness ingestion.  The investigation also identified that Mr. Choi routinely provided unauthorized carries for methadone daily witness ingestion patients. 

The Inquiry Committee considered this to be a serious matter under the Health Professions Act, and as such is published pursuant to section 39.3 of the Act.

Mr. Choi understands the seriousness of his actions in this matter and he has agreed to the following:

  1. That he will no longer dispense methadone as part of patients’ methadone maintenance treatment program.

  2. That if at any time in the future he wishes to dispense methadone as part of methadone maintenance treatment  program, he must receive approval from the College after meeting very specific requirements to dispense methadone.

  3. That he will review relevant legislative framework documents that include Health Professions Act, (“HPA”), Bylaws, Schedule F, Part 1, Community Pharmacy Standards of Practice, in its entirety; HPA, Bylaws, Schedule A, Code of Ethics; Professional Practice Policy #24 – Depot Shipments of Prescriptions; and Pharmacy Operations and Drug Scheduling Act, Bylaws, section 21 – Data Collection, Transmission of and Access to PharmaNet Data; and submit a Declaration of Understanding to the Complaints Resolution Officer that confirms his understanding and future compliance.

  4. That he will provide apology letters to all of the prescribers of those patients that he provided unauthorized methadone carries during August 2013 through to December 2013 and send copies of these letters to the College.

  5. That he will pay a fine in the amount of five thousand ($5,000) dollars.

  6. That a Letter of Reprimand will be placed on Mr. Choi’s College register.
Djavanmardi, Mansour/Native Vancouver Pharmacy (May 29, 2015)
(September 3, 2015 - Mansour Djavanmardi – Limits and conditions removed)

On May 27, 2015, pursuant to s. 20(3) of the Pharmacy Operations and Drug Scheduling Act, S.B.C. 2003, c. 77 and s. 35(1)(b) of the Health Professions Act, R.S.B.C. 1996, c. 183, the Inquiry Committee made an extraordinary order to suspend the pharmacy license of Native Vancouver Pharmacy, located at 108-50 East Hastings Street in Vancouver, pending completion of an investigation. This order was made in the interest of public safety following an inspection of the pharmacy by College inspectors, which raised serious concerns with respect to unhygienic conditions of the pharmacy, and the suitability of the premises to continue operating as a pharmacy. Examples of such conditions include, but are not limited to:

  • Mould found on the floors, walls, and food containers inside the dispensary
  • Fecal matter from mice and rats on the floor and other surfaces
  • Mouse and cockroach bait traps found in numerous locations within dispensary
  • Food, sugar, and coffee whitener left out in the open in the dispensary, accessible to insects and rodents
  • No hot running water
  • Dirty and dilapidated interior walls, fixtures, and furniture

The suspension will be effective as of June 12, 2015 and will continue until further notice. The Inquiry Committee, pursuant to s. 35(1)(a) of the Health Professions Act, for the purposes of public protection, also imposed limits and conditions on the practice of registrant Mansour Djavanmardi, the pharmacy manager of Native Vancouver Pharmacy, in that he may not be a pharmacy manager, effective June 12, 2015 pending completion of an investigation.

Pharmacist Registrant 6 (Feb 20, 2015)

Pharmacist Registrant 6 has satisfied the terms of an agreement reached with the Inquiry Committee dated October 3, 2010. Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed. The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 20 (Feb 18, 2015)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant to suspend his registration as a pharmacist effective February 18, 2015. The agreement remains in effect until further notice. The Inquiry Committee considers the agreement necessary to protect the public. The pharmacist registrant's name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 3 (Dec 22, 2014)

Pharmacist registrant has satisfied the terms of an agreement reached with the Inquiry Committee dated December 21, 2009.  Limits and conditions on pharmacist registrant’s registration as a pharmacist have now been removed.  The pharmacist registrant’s name has been withheld pursuant to 39.3(4) of the Health Professions Act.

Pharmacist Registrant 20 (Nov 17, 2014)
(February 18, 2015 - Registration Suspended)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant whereby the registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. Routine and random medical monitoring;

  2. Informing all managers and employers with whom he gains employment of his medical condition and the need to maintain vigilance with respect to recovery and the possibility of relapse, and the limits and conditions on his registration pursuant to the agreement;

  3. Ensuring that all managers and employers with whom he gains employment submits a written statement to the College declaring their awareness of his medical condition and the agreement;

  4. To return to work gradually, in accordance with the recommendations of his physician;

  5. To only be involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate and benzodiazepine type medications as long as a pharmacy assistant and/or pharmacy technician is also on duty at the same time and he takes oral Naltrexone (Revia) 50mg every day, witnessed by a pharmacy staff member at a pharmacy that agrees to perform this service, and that the pharmacy send the College written confirmation every month that the Registrant has done so, and the pharmacy is to contact the College immediately if there is any non-compliance by the Registrant.

  6. Being restricted from the following roles in his practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  7. Notifying the College of:

    1. all changes in his places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical provider.

The agreement will remain in place for a minimum of five years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.

Doan, Khiem Ngoc (Nov 10, 2014)

Pursuant to section 36 of the Health Professions Act, the Inquiry Committee has reached an agreement with registrant Khiem Doan to change his registration status to Former Pharmacist and is no longer a registrant of the College.  The registrant has agreed that he will not in future apply for registration or reinstatement to the College or apply for registration in any capacity by a governing body for a pharmacy in another province or foreign jurisdiction.

Lewis, Christopher James (Aug 23, 2014)
(AUGUST 24, 2015 – LIMITS AND CONDITIONS REMOVED)

Christopher James Lewis has completed a term of suspension which ended on August 22, 2014, and his registration has been reinstated as of August 23, 2014.

Pharmacist Registrant 9 (Aug 19, 2014)
(August 6, 2015 – Partial undertakings removed)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant whereby the registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

  1. Routine and random medical monitoring;

  2. Informing all managers and employers with whom he gains employment of his medical condition and the need to maintain vigilance with respect to recovery and the possibility of relapse, and the limits and conditions on his registration pursuant to the agreement;

  3. Ensuring that all managers and employers with whom he gains employment submits a written statement to the College declaring their awareness of his medical condition and the agreement;

  4. To return to work gradually, in accordance with the recommendations of his physician;

  5. To not work alone for a period of six months after returning to work in a pharmacy setting, meaning that he must never be the sole pharmacist in attendance at any time and that there must be another pharmacist in good standing working with him at all times;

  6. Not being involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate and benzodiazepine type medications;

  7. Being restricted from the following roles in his practice:

    1. an owner or manager of a pharmacy;
    2. a director of a corporation that owns a pharmacy; and
    3. a preceptor.

     

  8. Notifying the College of:

    1. all changes in his places of employment as a pharmacist
    2. all changes in residential address and phone number; and
    3. all changes in medical provider.

The agreement will remain in place for a minimum of two years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.

Pages